GRDX — GridAI Technologies Share News
0.000.00%
Last trade - 00:00- $39.97m
- $45.06m
- $0.04m
U.S. STOCKS ON THE MOVE-Arm holdings, Cruise operators, Crypto stocks
U.S. STOCKS ON THE MOVE-PFSweb, copper miners, cruise operators
Brief: First Wave Biopharma Says On September 13, Entered Into A License Agreement With Sanofi
Brief: First Wave Biopharma Announces Exclusive Global License Agreement For Capeserod From Sanofi
First Wave rises on global licensing deal with Sanofi for gastro disease treatment
Brief: First Wave Biopharma says Received Nasdaq Letter That co does not comply With Minimum Bid Price Requirement
Brief: First Wave Biopharma - On Aug 17, Received Letter From Nasdaq Indicating That Co Was Not In Compliance With Minimum Stockholders' Equity Requirement
First Wave plunges as genetic disorder drug may fail mid-stage study
U.S. STOCKS ON THE MOVE-Cryoport, cybersecurity firms, China ADRs
First Wave falls as genetic disorder drug 'likely' to fail in study
Brief: First Wave Biopharma Chairman And CEO Issues Letter To Stockholders
Brief: First Wave Biopharma Says Final Patient Dosed In Phase 2 Span Clinical Trial Of Enhanced Adrulipase Formulation
Brief: First Wave Biopharma Inc Files For Shelf Of Up To 3.4 Mln Shares Of Common Stock - SEC Filing
Refinitiv Newscasts - US Day Ahead: Fed seen on hold this week after inflation data
First Wave soars on reaching enrollment target in pancreatic disorder drug trial
U.S. STOCKS ON THE MOVE-Home Depot, Netflix, Bunge
U.S. STOCKS ON THE MOVE-Manchester United, China ADRs, Adobe
First Wave gains on reaching enrollment target in pancreatic disorder drug trial
Brief: First Wave Biopharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial In Cystic Fibrosis